Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
08 March, 2021 11:09 IST
Indigo Paints IPO subscribed 117 times on final day
Source: IRIS | 22 Jan, 2021, 07.48PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

The Rs 11,700 million initial public offering  (IPO) of Indigo Paints has received a tremendous response from investors by getting 117 times subscription so far on January 22, the final day of bidding.

Investors bid for over 645.7 million equity shares against the IPO size of 55.18 lakh shares.

Qualified Institutional Buyers (QIB) witnessed a subscription of 189.6 times and that of Non-institutional investors (NII) was subscribed 263 times their portion. The retail investors have put in 15.93 times bids against their reserved portion, and the employees' portion was subscribed 2.49 times.

Indigo Paints was the second IPO of 2021 after IRFC. The IPO closes today and is expected to be listed just a day after the Union Budget.

Indigo Paints on January 19 had raised Rs 3,480 million via anchor book at the higher end of the price band of Rs 1,488-1,490 per share.

The public issue comprises of a fresh issue of Rs 3,000 million and an offer for sale of 58.40 lakh equity shares by investors (Sequoia Capital India Investments IV and SCI Investments V) and promoter Hemant Jalan.

 Post Comment
Name Email
Security Code type    into this box
Meera Industries jumps on winning export order worth USD 180,000 - 08-Mar-2021 12:03
Jagran Prakashan plans to buyback shares worth Rs 1,180 mn - 08-Mar-2021 09:27
Kotak Mahindra Bank divests 10% stake in ECA Trading Services to its arm - 08-Mar-2021 09:07
Hero MotoCorp February sales crosses 5 lakh units - 05-Mar-2021 17:57
PVR launches new six-screen property in Mysuru - 05-Mar-2021 16:55
Voltas strong performance raises expectations of blockbuster summer sales: Motilal Oswal - 05-Mar-2021 13:27
Unichem Lab gets USFDA nod for Guanfacine Tablets - 05-Mar-2021 13:03
Buy Gland Pharma; target price of Rs 2,700: Motilal Oswal - 05-Mar-2021 12:54
RITES board to consider second interim dividend on March 12 - 05-Mar-2021 12:44
Mexico's GigNet selects Tejas Networks for its Metro Optical network in Cancun - 05-Mar-2021 12:32
Wipro-Capco acquisition- A Bold Move; REDUCE: IDBI Capital - 05-Mar-2021 11:44
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer